AVR anteris technologies global corp.

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-4

  1. 1,301 Posts.
    The trial passed 2a and they are moving in to the next phase
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.88
Change
-0.300(5.79%)
Mkt cap ! $75.66M
Open High Low Value Volume
$5.15 $5.15 $4.88 $40.78K 8.117K

Buyers (Bids)

No. Vol. Price($)
1 202 $4.90
 

Sellers (Offers)

Price($) Vol. No.
$5.09 5116 3
View Market Depth
Last trade - 10.19am 21/07/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.